CeNeS
Cambridge
About CeNeS
CeNeS is a biopharmaceutical company that develops and commercializes drugs for pain control, sedation and other CNS disorders.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $23.2M
- Funding stage: M&A
- Last round: Series Unknown (Dec 2006)
- Website: cenes.com
- Phone: 781-255-6700
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Canonical: https://fsome.com/organization/cenes-2953467 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.